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1  | BACKGROUND
More than 200 000 U.S. women are diagnosed with, and approx-
imately 40 000 die of, breast cancer annually.1 Disparities exist 
for ethnic minorities both for type of breast cancer diagnosed and 
across the care spectrum. This has been studied best and is most 
marked for African American women; however, particularly in the 
areas of disease stage, tumor characteristics, and processes of care, 
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Objective: To investigate mammography facilities’ follow- up times, population vul-
nerability, system- based processes, and association with cancer stage at diagnosis.
Data Sources: Prospectively collected from San Francisco Mammography Registry 
(SFMR) 2005- 2011, California Cancer Registry 2005- 2012, SFMR facility survey 
2012.
Study Design: We examined time to biopsy for 17 750 abnormal mammogram results 
(BI- RADS 4/5), categorizing eight facilities as short or long  follow- up based on pro-
portion of mammograms with biopsy at 30 days. We examined facility population 
vulnerability (race/ethnicity, language, education), and system processes. Among 
women with a cancer diagnosis, we modeled odds of advanced- stage (≥IIb) cancer 
diagnosis by facility follow- up group.
Data Extraction Methods: Merged SFMR, Cancer Registry and facility survey data.
Principal Findings: Facilities (N = 4) with short follow-up completed biopsies by 
30 days for 82% of mammograms compared with 62% for facilities with long  follow- up 
(N = 4) (P < 0.0001). All facilities serving high proportions of vulnerable women were 
long  follow- up facilities. The long  follow- up facilities had fewer radiologists, longer 
biopsy appointment wait times, and less communication directly with women. Having 
the index abnormal mammogram at a long  follow- up facility was associated with 
higher adjusted odds of advanced- stage cancer (OR 1.45; 95% CI 1.10- 1.91).
Conclusions: Providing mammography facilities serving vulnerable women with ap-
propriate resources may decrease disparities in abnormal mammogram follow- up and 
cancer diagnosis stage.
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there are also considerable data to suggest differences for immigrant 
women and women living in poverty regardless of race- ethnicity.2-14
Mammography can detect breast cancer that is not otherwise 
clinically detectable. For this reason, mammography has been 
broadly implemented as a means to achieve early detection and 
treatment of breast cancer.15 However, because mammography is 
not 100% specific and can only identify suspicious lesions, all ab-
normal mammogram results require either subsequent imaging or 
biopsy until the abnormality is defined as either cancer or benign.16 
This additional evaluation must be done in a timely manner in order 
to avoid delays in cancer diagnosis and to have the potential to 
achieve the benefits of screening.17-19
While there is no definitive definition of the length of time be-
tween an abnormal mammogram and resolution that constitutes a 
delay, there is evidence that more than 3 months between presen-
tation and treatment initiation can lead to more advanced cancer at 
diagnosis.20-22 Additionally, a recent simulation study reported that, 
with each additional 3- month delay between an abnormal mammo-
gram and subsequent diagnostic testing, the distribution of breast 
cancers shifted toward a higher stage.19 Delays in resolution of ab-
normal mammogram results can cause women psychological dis-
tress, including anxiety and depression.23-25 Multiple studies have 
found delays to be common, with estimates ranging from 20% to 
40% of abnormal results having delayed follow- up, and have delin-
eated a disparity in which groups experience them: Delays are more 
prevalent for low socioeconomic status (SES) and minority women 
than for higher SES and White women.3,5,26-33
However, examinations of the disparity in follow- up care after an 
abnormal mammogram frequently emphasize the individual woman, 
her attitudes, intentions, and follow- up behavior.34-37 Two studies 
have observed that facilities serving vulnerable women have longer 
follow- up times for abnormal mammogram results.38,39 This demon-
strates the need to assess processes of care at the facility level that 
may be contributing to timely or delayed follow- up. While one study 
has demonstrated a relationship between communication processes 
and timeliness of follow- up after an indeterminate mammogram re-
sult (Breast Imaging- Reporting and Data System—BI- RADS—0), no 
studies have investigated facility processes of care for more con-
cerning BI- RADS 4 or 5 results and follow- up,40 or their relationship 
to disparities in follow- up.
In this study, we examined whether facilities with longer fol-
low- up times for BI- RADS 4 or 5 results serve a disproportionate 
number of vulnerable women compared with those with shorter 
follow- up times and further examined facility characteristics associ-
ated with longer follow- up times. Secondarily, we assessed whether 
stage of breast cancer diagnosis was associated with the facility’s 
timeliness of follow- up.
2  | METHODS
2.1 | Setting and data sources
This study is based on the San Francisco Mammography Registry 
(SFMR), a research registry of women having breast imaging at mam-
mography facilities (“facilities”) in San Francisco and its surrounding 
counties (Figure 1).41 Facilities submit clinical data to the registry, 
including demographic information about women, mammography 
results, diagnostic examinations, and biopsy procedures for those 
women who give passive permission for their clinical data to be 
used for research. The SFMR annually links to the California Cancer 
Registry to collect information on cancer outcomes form the prior 
year.42
In 2012, we conducted a survey of the 13 facilities participating 
in the SFMR at that time to examine processes of care, including 
staffing, diagnostic appointment availability, tracking, communi-
cation practices with women and referring providers, and demo-
graphics of the population served not otherwise available in the 
SFMR (e.g., limited English proficiency [LEP]). We contacted the 
F IGURE  1 Sources of data and measure derivation from merged dataset [Color figure can be viewed at wileyonlinelibrary.com]
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lead radiologist at each facility and asked them to indicate the 
best person—head technician or administrator—to participate in a 
survey about processes of care at that facility. Once identified, we 
contacted that individual by email and then set up a time in per-
son or by telephone to administer the survey. For this analysis, we 
included data from the eight facilities with both complete facility 
and complete biopsy data in the 6 years prior to the facility survey 
(2005- 2011). These facilities were in San Francisco and Marin coun-
ties included an academic medical center, two public hospitals, and 
multiple community hospitals.
2.2 | Measures
2.2.1 | Time to follow- up
We defined time to follow- up as the time between an index abnor-
mal mammogram and biopsy. We included as index mammograms 
those done at one of the eight facilities between 1 January 2005 and 
31 December 2011 with a BI- RADS result of 4 (suspicious for malig-
nancy) or 5 (highly suggestive of malignancy) and a recommendation 
for tissue biopsy.16 If a woman had multiple BI- RADS 4 or 5 results, 
we included only the first one in the study period.
2.2.2 | Short vs long  follow- up facilities
We aggregated all of the examinations for each facility over the study 
period and plotted their mean time to follow- up in days. Examining 
these plots, we found a clear separation in follow- up at 30 days after 
the index mammogram, with half the facilities achieving biopsy fol-
low- up for at least 75% of abnormal BI- RADS 4/5 mammograms at 
30 days (range 75%- 95%) and the other half achieving follow- up for 
less than 75% at 30 days (range 41%- 63%). Using 75% follow- up at 
30- day cut- off, we categorized each facility as having “short” (≥75%) 
or “long” (<75%) follow- up.
2.2.3 | Population served by facility
Using the SFMR database for all women with any type of mam-
mogram during the study period, we measured the distribution of 
race/ethnicity (African American, Asian, Latino, White) and edu-
cational attainment (<high school graduate, high school graduate/
GED, some college, ≥college) for the population served by that 
facility. From the facility survey, we measured the proportion of 
the total population served with LEP. We then created three “vul-
nerable population” measures using a threshold of one standard 
deviation greater than the mean for all included facilities combined 
for that measure.39 The three vulnerable population measures 
were as follows: minority served (>59% African American, Asian, 
or Latina women), lower educational attainment served (>18% 
with <high school education), and LEP served (>36% with LEP). We 
then combined the three measures to create a vulnerable popula-
tion served index (0 measures = none; 1- 2 measures = moderate; 3 
measures = high).
2.2.4 | Facility characteristics and processes
Using the SFMR database for all diagnostic examinations regardless 
of result, we created a measure of examination volume (diagnostic 
examinations/week). From the SFMR facility survey, we measured 
staffing adequacy (number of full- time- equivalent or FTE radiolo-
gists reading per week), access (number of days to the next avail-
able biopsy appointment), tracking system (commercial integrated 
electronic vs homegrown spreadsheet or paper system), and com-
munication of results (facility contacts provider directly beyond the 
report; facility contacts woman directly beyond the required letter; 
perception of who is primarily responsible for ensuring follow- up: 
facility, referring provider, both).
2.2.5 | Cancer diagnosis
Using the merged SFMR- California Cancer Registry data, we in-
cluded any breast cancer diagnosis within 1 year of the index BI- 
RADS 4/5 mammogram. Diagnoses were classified as early (0/I/IIa) 
or advanced stage (IIb/III/IV) according to summary stage available 
in the cancer registry.43
2.3 | Analysis
We examined time to follow- up for short and long  follow- up groups 
using a plot of cumulative percent and compared follow- up rates at 
30, 90, and 120 days using chi- square statistics. We then compared 
facility characteristics, processes, and vulnerable population meas-
ures by short vs long  follow- up group using descriptive statistics.
Among women with a cancer diagnosis, we modeled the odds of 
being diagnosed with an advanced- stage cancer according to hav-
ing the index mammogram at a facility with short- vs long- facility 
follow- up. We further modeled those odds adjusting for individual 
characteristics known to be associated with cancer stage at diag-
nosis, including the woman’s age, having a first- degree relative with 
breast cancer, race/ethnicity, and the number of months from a prior 
mammogram to the index BI- RADS 4/5 mammogram. In building our 
multivariate model, we accounted for clustering of patients within 
facilities, and we assessed the relative fit of model variations by 
comparing Akaike’s information criterion values between models. 
We used a mixed effects model specifying facility as the random 
effect parameter and all other covariates as fixed effects.
3  | RESULTS
3.1 | Short and long  follow- up facilities
Our study sample included 17 750 index mammograms with BI- 
RADS 4/5 assessment and recommendation for tissue biopsy fol-
low- up. The short  follow- up facilities achieved follow- up at 30 days 
for a significantly higher proportion of mammograms compared to 
the long  follow- up facilities (82% vs 62.0%; P < 0.0001). The differ-
ence between the short and long  follow- up facilities was smaller 
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F IGURE  2 Time to biopsy after a  
BI- RADS 4 or 5 mammogram result 
by short and long  follow- up facility 
group [Color figure can be viewed at 
wileyonlinelibrary.com]
TABLE  1 Vulnerable population served and facility characteristics for San Francisco mammography registry facilities 2005- 2012 by 
facility short and long  follow- up group (N = 8 facilities)
Short  follow- up facility group (four facilities; 
15 203 mammograms)
Long  follow- up facility group (four 
facilities; 2547 mammograms)
Vulnerable population served (N, %)
Minority served: >59% minority patients 0 3 (75.0)
Lower education attainment served: >18% patients 
with less than a high school education
0 2 (50.0)
Limited English proficient served: >36% patients with 
LEP
0 2 (50.0)
Vulnerable population served index
None (0) 4 (100) 1 (25.0)
Moderate (1- 2) 0 1 (25.0)
High (3) 0 2 (50.0)
Volume, staffing adequacy, and access (mean, SD)
Average diagnostic volume/week 87 (77) 12 (15)
FTE radiologists reading diagnostic examinations/
week
5.5 (3.3) 3.3 (1.6)
Diagnostic volume/FTE ratio 250 (173) 379 (209)
Days to next available biopsy appointment 1.8 (1.3) 7.5 (6.8)
Tracking and communication (N, %)
Tracking system
Commercial 4 (100) 3 (75.0)
Homegrown 0 1 (25.0)
Facility contacts patient directly 4 (100) 2 (50.0)
Facility contacts physician directly 2 (50.0) 3 (75.0)
Responsibility for ensuring follow- up
Facility 3 (75.0) 0
Referring MD 0 1 (25.0)
Both 1 (25.0) 3 (75.0)
FTE, full- time- equivalent; LEP, limited English proficiency.
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but remained significant at 60 days (87.1% vs 78.5%; P < 0.001) and 
at 90 days (88.2% vs 83.7%; P < 0.001). The gap between the two 
groups was minimal by 120 days, or 4 months after the index mam-
mogram, although the difference remained statistically significant 
(88.8% vs 85.4%; P < 0.001) (Figure 2). At 12 months, 10% of mam-
mograms from short  follow- up facilities and 12% of mammograms 
from long  follow- up facilities did not have a documented biopsy in 
the SFMR.
3.2 | Population served by follow- up group
None of the short  follow- up facilities met criteria for any of the 
vulnerable population measures, whereas three of the four long 
 follow- up facilities met criteria for at least one of the measures, with 
two of those meeting criteria for all three measures indicating that 
they served a high proportion of vulnerable women (Table 1).
Within short  follow- up facilities, there was no difference in 
percent with follow- up at 30 days by race/ethnicity (82% overall). 
However, within long  follow- up facilities, Black/African American 
women had the lowest percent with follow- up at 30 days, followed 
by Chinese women (53% Black, 60% Chinese, 65% other Asians, 64% 
Latinas, 64% White; P = 0.03). Those with the lowest educational at-
tainment (<high school) had a similar rate of follow- up to the over-
all group in the short  follow- up group (81.8 vs 81.3; P = 0.76), but a 
slightly lower rate of follow- up in the long follow- up group (61.4 vs 
63.2; P = 0.26).
3.3 | Facility characteristics and processes
The long  follow- up facilities, on average, had lower volume of di-
agnostic examinations as well as fewer radiologists available to 
read those examinations, and a higher volume/FTE ratio than the 
short follow- up facilities (Table 1). The long  follow- up facilities also 
reported longer waits for a biopsy appointment. While all but one 
of the eight facilities used a commercial tracking system, the two 
follow- up groups differed in their approach to communication. All 
short follow- up facilities, but only two of the long follow- up facili-
ties, reported that in addition to the legally mandated result letter, 
they contacted women directly to inform them of a BI- RADS 4 or 5 
result. While long follow- up facilities reached out to the referring 
provider after a woman’s BI- RADS 4 or 5 result, they also perceived 
that the referring provider had equal or greater responsibility than 
the mammography facility for ensuring follow- up was completed. By 
contrast, three of the short  follow- up facilities perceived that the 
responsibility lay primarily with the mammography facility and not 
with the referring provider.
3.4 | Cancer diagnosis
There were 3099 cancer diagnoses in the 12 months following an 
index mammogram during the study period (Table 2). Of these, 480 
were advanced stage (IIb or higher). A higher proportion of women 
with an advanced- stage cancer (vs earlier stage) had no record in 
the dataset of a mammogram prior to the index mammogram (8.1% 
vs 3.5%; P = 0.000). Among women with a prior mammogram in the 
dataset, women with an advanced- stage cancer had a longer time 
interval between the previous mammogram and the index mammo-
gram (736 vs 652 days; P = 0.03).
Women with an index mammogram at a long (vs short) follow- up 
facility had 1.5 odds of being diagnosed at a higher breast cancer 
stage (OR 1.53; 95% CI 1.14- 2.05). This result was robust to adjust-
ing for the woman’s age, family history of breast cancer, race/eth-
nicity, and time between the previous mammogram and the index 
mammogram (OR 1.45; 95% CI 1.10- 1.91). Time between previous 
and index mammogram was marginally significant in the adjusted 
model (OR 1.01; 95% CI 1.00- 1.01).
4  | DISCUSSION
We leveraged a unique dataset combining clinical data on thousands 
of women with abnormal mammogram results with information on 
the facilities serving those women to examine the relationship among 
follow- up time, processes of care, and the vulnerability of the popu-
lations served by the facilities. We found that facilities serving a high 
proportion of vulnerable women—minorities, and those with low 
educational attainment or LEP—have long  follow- up time to biopsy 
for abnormal mammogram results suspicious for or highly suggestive 
of cancer. These facilities report processes of care that demonstrate 
fewer resources than their short  follow- up counterparts. They have 
Short follow- up facility group (four 
facilities/2495 patients) N (%)
Long follow- up facility group (four 
facilities/604 patients) N (%)
Cancer stage
0 705 (28.3) 146 (24.2)
I 974 (39.0) 204 (33.8)
IIa 421 (16.9) 116 (19.2)
IIb 175 (7.0) 55 (9.1)
III(a,b,c) 150 (6.0) 50 (8.3)
IV 34 (1.4) 16 (2.6)
Missing 36 (1.4) 17 (2.8)
TABLE  2 Stage of cancer diagnosis for 
cancers diagnosed after an abnormal 
mammogram at San Francisco 
mammography facilities 2005- 2012 by 
facility short and long  follow- up group 
(N = 3099 Women)
     |  231Health Services ResearchKARLINER Et AL.
less FTE radiologists reading diagnostic examinations, longer wait 
times for biopsy appointments, and less direct communication with 
women, with the expectation that the responsibility for this com-
munication lies primarily with the referring provider. These findings 
point to the system processes that will need to be improved to ad-
dress disparities in follow- up for vulnerable women after an abnor-
mal mammogram.
In comparison, within short  follow- up facilities, minority women 
and those with low educational attainment have rates of 30- day 
follow- up equal to White women and educated women. However, 
within long  follow- up facilities, Black and Chinese women, and 
women with less than a high school education have lower rates of 
30- day follow- up than other groups. This indicates that not only are 
vulnerable women more likely to be served by lower resourced facil-
ities, many of them fare worse than their White and more educated 
counterparts at those facilities. It also suggests that more resourced 
facilities are able to deliver equal care across groups regardless of 
race- ethnicity or education.
For women diagnosed with cancer, getting initial care at one of 
these less resourced mammography facilities with longer follow- up 
times after an abnormal mammogram is associated with a higher 
likelihood of being diagnosed with an advanced- stage cancer. This 
is true regardless of race/ethnicity. In other words, Asian, Black, and 
Latina women diagnosed with breast cancer who received care at 
mammography facilities with short follow-up times were less likely 
than their counterparts who received care at facilities with long 
 follow- up times to be diagnosed with an advanced- stage breast can-
cer. This suggests that at least some of the disparity in cancer stage 
at diagnosis for minority women is related to the systems in which 
those women receive their care. This connection between disparities 
in place of care and an advanced stage of breast cancer at diagnosis 
drives home the imperative for addressing follow- up procedures at 
the facility and health system level.
However, it may be that there are also individual factors contribut-
ing to this advanced- stage diagnosis, some of which are unrelated and 
others related to follow- up times. For example, unrelated to follow- up, 
women with dense breasts and obese women are more likely to be di-
agnosed with advanced disease, and there are population differences 
for these factors.44,45 Other individual and social factors likely play 
a role in follow- up. In our sample, the advanced cancer group had a 
longer mean interval between a previous mammogram and the index 
abnormal mammogram, suggesting that the delay in follow- up of the 
abnormal mammogram may not be the only delay contributing to an 
advanced cancer diagnosis. This prolonged interval itself may have 
multiple causes, including both individual and systems- based reasons. 
Most previous examinations of the disparity in follow- up care after 
an abnormal mammogram have emphasized the individual woman, 
her attitudes, intentions, and behavior.34-37 However, the association 
we have found that vulnerable women are more likely to receive care 
from mammography facilities with long  follow- up belies the belief 
that the burden for timely follow- up lies with the woman alone. Our 
findings highlight the need to improve care delivery and communica-
tion at the level of the mammography facility.
While there have been some successful interventions to decrease 
delays, these have largely focused on patient navigation in an attempt 
to address individual barriers to follow- up.46,47 While navigation 
programs have been successful, this personalized intervention guid-
ing individual women through the complexities of breast cancer di-
agnosis does not seem to have its impact for at least 3 months after 
the abnormal mammogram.48,49 Navigation’s focus on the individ-
ual appears to be most successful for the patients at highest risk of 
nonfollow- up, yet those patients are also the most challenging to 
achieve follow- up for even in the context of a navigation program.50,51 
Thus, the focus of resource- intensive navigation programs addressing 
individual barriers to follow- up may need to be on the most at- risk 
patients. However, there remains a need for system- level solutions 
that can reach more women. Our findings suggest that there may be 
additional system- based strategies specifically related to resources af-
fecting staffing, access, communication, and coordination of care that 
facilities could employ to reduce disparities in follow- up time and po-
tentially cancer stage at diagnosis.
Our study has several limitations. Our data encompassed two 
counties in a single region, which may not be representative of other 
regions nationally. It is unclear exactly what is driving the variation in 
populations served by short and long follow- up mammography facili-
ties—preference, referral patterns, insurance coverage, neighborhood 
proximity, or other factors. We were not able to examine these factors 
in our dataset. Additionally, it is possible that a woman who had an 
index mammogram at one facility subsequently had her biopsy at an-
other. While we were not able to capture biopsies performed outside 
of our eight facilities, we were able to capture biopsies done at any 
of the eight facilities included in the study regardless of the facility in 
which the index mammogram was performed. Finally, the time frame 
of our study only included the first years of the Affordable Care Act 
(ACA). Under the ACA, more traditionally underserved women have 
established primary care and now receive preventive services such 
as mammograms.52 This influx of newly insured women may have 
directed low SES women to both short and long  follow- up facilities; 
however, if the long  follow- up facilities do not have the resources to 
enhance their staffing, access, and communication capabilities, this 
could potentially worsen rather than lessen disparities.
In conclusion, we found that in our sample of mammography fa-
cilities, those serving high proportions of vulnerable women have 
long  follow- up times to biopsy, and their processes of care including 
adequacy of staffing, access, and communication practices differ 
from facilities with short  follow- up times. This places minority and 
lower SES women with breast cancer at higher likelihood of being 
diagnosed with advanced- stage disease. Providing mammography 
facilities serving vulnerable women with appropriate resources may 
decrease disparities in abnormal mammogram follow- up and cancer 
diagnosis stage.
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